Literature DB >> 2440696

Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site.

J L Moreau, M Nabholz, T Diamantstein, T Malek, E Shevach, J Thèze.   

Abstract

A new rat monoclonal antibody (5A2) directed against the mouse interleukin 2 receptor (IL2R) is described. This antibody binds specifically to IL2R+ cells, competes with both cold IL2 and 125I-labeled IL2 for the IL2-binding site and inhibits IL2-induced T cell proliferation. This reagent was compared to five previously characterized rat monoclonal antibodies directed against the p55 subunit of the mouse IL2R. The capacity of all the antibodies to inhibit IL2-induced T cell proliferation was assessed. The relationship of these eight antibodies to each other and to the IL2-binding site was studied by cross-inhibition assays, and by Scatchard analysis of the data. The results indicate that the six monoclonal antibodies recognize epitopes in three areas of the p55 subunit of the mouse IL2R. Antibodies against two of the clusters affect IL2 binding. One cluster defined by 3 antibodies is probably located in the area of the IL2-binding site as there is competitive inhibition between IL2 and antibodies against this cluster. A single antibody directed against an epitope outside this cluster appears to inhibit IL2 binding by inducing a conformational change in the p55 subunit of the IL 2R. Two other antibodies identify a third region which is not involved in the formation of the binding site.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440696     DOI: 10.1002/eji.1830170706

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes.

Authors:  M F Saron; B Shidani; M A Nahori; J C Guillon; P Truffa-Bachi
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.

Authors:  H D Volk; O Josimovic-Alasevic; M Gross; T Diamantstein
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

Authors:  C Uyttenhove; R J Simpson; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.

Authors:  Erika T Hayes; Cassidy E Hagan; Liliane Khoryati; Marc A Gavin; Daniel J Campbell
Journal:  J Immunol       Date:  2020-10-14       Impact factor: 5.422

5.  Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes.

Authors:  Tsukasa Nabekura; Luke Riggan; Andrew D Hildreth; Timothy E O'Sullivan; Akira Shibuya
Journal:  Immunity       Date:  2019-12-03       Impact factor: 31.745

6.  Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factors.

Authors:  C Rusterholz; P C Henrioud; M Nabholz
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Inhibition of murine T-cell responses by anti-oxidants: the targets of lipo-oxygenase pathway inhibitors.

Authors:  J Dornand; M Gerber
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

8.  IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells.

Authors:  Natasha C Ward; Aixin Yu; Alejandro Moro; Yuguang Ban; Xi Chen; Sunnie Hsiung; James Keegan; Jaren M Arbanas; Martine Loubeau; Anil Thankappan; Aaron P Yamniuk; Jonathan H Davis; Mary Struthers; Thomas R Malek
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

9.  Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals.

Authors:  A Rebollo; A Silva
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

10.  Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.

Authors:  K Burkhardt; T E Mandel; T Diamantstein; M S Loughnan
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.